Related Experiment Video
Updated: Jul 18, 2026
08:33
A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
Published on: January 5, 2024
The low-dose dexamethasone suppression test in fibromyalgia
Katja Wingenfeld1, Dieter Wagner, Iris Schmidt
1Department of Psychobiology, University of Trier, Trier, Germany.
Journal of Psychosomatic Research
|December 26, 2006
Summary
Fibromyalgia patients show increased hypothalamic-pituitary-adrenal (HPA) axis feedback sensitivity, particularly at the adrenal level. This suggests altered stress hormone regulation in fibromyalgia syndrome (FMS).
Area of Science:
- Endocrinology
- Neuroscience
- Psychiatry
Background:
- Fibromyalgia syndrome (FMS) is linked to reduced cortisol secretion.
- Posttraumatic stress disorder (PTSD) also involves hypocortisolism and heightened HPA axis feedback sensitivity.
- Trauma and PTSD are associated with FMS, prompting investigation into HPA axis function in FMS.
Purpose of the Study:
- To investigate whether patients with fibromyalgia exhibit increased hypothalamic-pituitary-adrenal (HPA) axis feedback sensitivity.
- To compare HPA axis response to dexamethasone suppression in FMS patients versus healthy controls.
Main Methods:
- 15 female FMS patients and 20 healthy controls underwent a dexamethasone suppression test.
- Blood samples were collected to measure adrenocorticotropin (ACTH), cortisol, and dexamethasone levels.
- Measurements were taken at baseline and after dexamethasone administration.
Main Results:
- No baseline differences in ACTH or cortisol were observed between groups.
- FMS patients demonstrated greater cortisol suppression after dexamethasone compared to controls.
- Increased ACTH/cortisol ratios were found in FMS patients post-dexamethasone, indicating enhanced feedback sensitivity.
Conclusions:
- Fibromyalgia syndrome is associated with increased sensitivity to glucocorticoid feedback.
- This heightened sensitivity appears to manifest at the adrenal level.
- Findings suggest dysregulation of the HPA axis in FMS patients.
